Kala Pharmaceuticals Announces Up to $31 Million Private

Nov 28, 2022 · Kala Pharmaceuticals Announces Up to $31 Million Private Placement Financing November 28, 2022 16:01 ET | Source: Kala Pharmaceuticals, Inc. Kala Pharmaceuticals, Inc.

CouponFollow Extension

$31
OFF

Kala Pharmaceuticals Announces Up To $31 Million Private

1 week from now

Nov 28, 2022 · Kala Pharmaceuticals Announces Up to $31 Million Private Placement Financing November 28, 2022 16:01 ET | Source: Kala Pharmaceuticals, Inc. Kala Pharmaceuticals, Inc.

globenewswire.com

$31
OFF

KALA - Kala Pharmaceuticals Announces Up To $31 Million...

1 week from now

ARLINGTON, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, …

marketwirenews.com

$31
OFF

Kala Pharmaceuticals Announces Up To $31 Million Private

1 week from now

Nov 28, 2022 · Kala Pharmaceuticals, Inc. announced that it has entered into a definitive agreement with a life sciences-focused investor for the sale, in a private placement priced at …

biospace.com

$31
OFF

Kala Pharmaceuticals Launches $31 Million Private Placement

1 week from now

-- Kala Pharmaceuticals said Monday it has struck a deal to sell up to $31 million shares and series E convertible non-redeemable preferred stock to a life sciences-focused investor. The...

marketscreener.com

$31
OFF

Kala Pharmaceuticals Enters Into Private Placement Financing For …

1 week from now

Nov 28, 2022 · Kala Pharmaceuticals (NASDAQ:KALA) on Monday said it had entered into a private placement financing for proceeds of up to $31M. KALA will sell shares of its common …

seekingalpha.com

$31
OFF

Kala Pharmaceuticals Announces Up To $31 Million Private …

1 week from now

ARLINGTON, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, …

yahoo.com

$31
OFF

Kala Pharmaceuticals Announces Up To $31 Million Private …

1 week from now

KALA Kala Pharmaceuticals Inc Kala Pharmaceuticals Announces Up to $31 Million Private Placement Financing. ARLINGTON, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Kala …

advfn.com

$31
OFF

Kala Pharmaceuticals Announces Up To $31 Million Private …

1 week from now

(2022-11-28 | NDAQ:KALA) Kala Pharmaceuticals Announces Up to $31 Million Private Placement Financing (2022-11-28 | NDAQ:KALA) Kala Pharmaceuticals Announces Up to $31 …

stockhouse.com

$31
OFF

Kala Pharmaceuticals Announces Up To $31 Million Private …

1 week from now

ARLINGTON, Mass., Nov. 28, 2022 -- Kala Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of …

marketscreener.com

$31
OFF

Kala Pharmaceuticals (KALA) Announces Up To $31 Million Private ...

1 week from now

Kala Pharmaceuticals, Inc. (NASDAQ: KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare …

streetinsider.com

$31
OFF

Kala Pharmaceuticals Announces Up To $31 Million Private …

1 week from now

Nov 28, 2022 · Read Press Release for Kala Pharmaceuticals (KALA) published on Nov. 28, 2022 - Kala Pharmaceuticals Announces Up to $31 Million Private Placement Financing. ... Top …

marketchameleon.com

$31
OFF

Kala Pharmaceuticals Announces Up To $31 Million Private …

1 week from now

ARLINGTON, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the... interface …

knowledia.com

$31
OFF

Kala Pharmaceuticals Announces Up To $31 Million Private …

1 week from now

Nov 28, 2022 · Kala Pharmaceuticals, Inc. (NASDAQ:KALA) has entered into a definitive agreement for a private placement to raise up to $31 million. The first tranche includes the sale …

stocktitan.net

$31
OFF

Kala Pharmaceuticals Announces Up To $31M Private Placement …

1 week from now

ARLINGTON, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, …

citybiz.co

$31
OFF

Kala Pharmaceuticals Announces Up To $31 Million Private Placeme

1 week from now

ARLINGTON, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (KALA), a clinical-stage biopharmaceutical company dedicated to the research, 🚀 Enjoy a 7-Day Free …

gurufocus.com

$31
OFF

Kala Pharmaceuticals Announces Up To $31 Million Private …

1 week from now

ARLINGTON, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, …

financialcontent.com

$31
OFF

KALA BIO, Inc. (KALA) Stock Price, Quote & News - Stock Analysis

1 week from now

4 days ago · Kala Pharmaceuticals Announces Up to $31 Million Private Placement Financing. ARLINGTON, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. …

stockanalysis.com

$31
OFF

Kala Pharmaceuticals Announces Up To $31 Million Private

1 week from now

KALA KALA BIO Inc Kala Pharmaceuticals Announces Up to $31 Million Private Placement Financing. ARLINGTON, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Kala …

advfn.com

FAQs about Kala Pharmaceuticals Announces Up to $31 Million Private Coupon?

What is Kala Pharmaceuticals?

Kala Pharmaceuticals is a biopharmaceutical company that develops therapeutics, with a focus on complex eye diseases. (Company Description: Kala Pharmaceuticals) ...

How much will Kala sell?

Under the terms of the agreement, Kala has agreed to sell in a first tranche an aggregate of 76,813 shares of its common stock at a price of $5.75 per share and an aggregate of 9,666 shares of its Series E Preferred at a price of $575.00 per share, for gross proceeds of approximately $6 million. ...

What happened to the Kala Pharmaceuticals Inc stock price?

The Kala Pharmaceuticals Inc stock price fell by -5.73% on the last day (Wednesday, 29th Mar 2023) from $15.72 to $14.82. The price has fallen in 6 of the last 10 days and is down by -11.2% for this period. The stock fluctuated 11.29% from a day low at $14.61 to a day high of $16.26. ...

Is Kala Pharmaceuticals Inc stock a buy or sell signal?

The Kala Pharmaceuticals Inc stock has a buy signal from the long-term moving average; however, it also holds a sell signal from the short-term moving average. Despite the short-term sell signal, the fact that the long-term average is above the short-term average indicates a general buy signal in the stock, giving a positive forecast for Kala Pharmaceuticals Inc stock. ...

Which companies do Kala bio investors own?

According to MarketBeat's aggregate information from watchlists, some companies that other KALA BIO investors own include Pfizer (PFE), Sorrento Therapeutics (SRNE), Dynavax Technologies (DVAX), Micron Technology (MU), Inovio Pharmaceuticals (INO), VBI Vaccines (VBIV), Amarin (AMRN), Bristol-Myers Squibb (BMY), NVIDIA (NVDA), and AbbVie (ABBV). ...

What is the expected price of Kala Pharmaceuticals Inc (KLA)?

For the upcoming trading day, we expect Kala Pharmaceuticals Inc to open at $15.23. The possible trading interval, based on the 14 day Average True Range, is +/-$2.54, which gives a possible range of $12.28 to $17.36. This gives a possible trading interval of up to $5.08 or down to $3.05 from the last closing price. ...